Comment on "The Inhibiting Fc Receptor for IgG, FcgRIIB, Is a Modifier of Autoimmune Susceptibility" F cgRIIB 129 2/2 female mice produce detectable levels of anti-nuclear autoantibodies (ANAs) at the age of 4-5 mo (1) . Moreover, these mice, compared with agematched wild-type C57BL/6 mice, exhibit a reduced expression of the Aim2 gene (a member of the Ifi200 gene family), activation of the IFN response, and the induction of certain IFN-inducible genes at the age of ∼8 wk (much earlier than the detection of ANAs) (2). The IFN-inducible genes include the Ifi202 gene (encoding for the p202 protein) from the Ifi200 gene family (2), which is located within the Nba2 lupus susceptibility interval (3, 4) . The interval also includes the Fcgr2b gene (4) . Given that increased nuclear levels of p202 protein in B6.Nba2 congenic female mice are associated with the production of ANAs (3, 4) 2/2 mice express increased levels of p202 protein ( Fig. 1 ) at the age of ∼8 wk, the observations by Boross et al. (5) support an interesting possibility that epistatic interactions between Fcgr2b and Ifi200 family genes contribute to an increased production of type I IFN and ANAs. Therefore, further work is needed to characterize these epistatic interactions to understand their role in the development of lupus disease.
Response to Comment on "The Inhibiting Fc Receptor for IgG, FcgRIIB, Is a Modifier of Autoimmune Susceptibility" I n our opinion, the comment of Choubey et al. deals with two issues: 1) the direct link between FcgRIIB and Ifi202 expression and 2) the role of If1202 as a systemic lupus erythematosus (SLE) susceptibility gene.
The Ifi202 gene is located in the flanking region of the Fcgr2b gene, which is of 129 origin in FcgRIIB 129 2/2 mice. As shown in the study of Jorgensen et al. (1), expression of the allelic variant of the Ifi202 gene present in the Nba2 interval of the NZB mouse is significantly higher compared with the Ifi202 expression in C57BL/6 mice. In our opinion, the explanation for the higher Ifi202 gene expression found in FcgRIIB 129 2/2 mice is due to the Sle16 haplotype of the 129-derived Fcgr2b flanking region, which most likely is the same as that of the NZB-derived Nba2 interval. On the basis of these data, we expect that in our FcgRIIB B6 2/2 mice, the Ifi202 expression is the same as in C57BL/6 mice.
However, these data do not exclude Ifi202 as a candidate SLE susceptibility gene. The goal of our study was to define the intrinsic role of FcgRIIB in the development of autoimmunity. For that purpose, we compared two FcgRIIB knockout mouse strains independently generated in two different genetic backgrounds. We demonstrated that in a pure C57BL/6 background, FcgRIIB deficiency is not sufficient to induce autoimmunity. We concluded that epistatic interactions between one or more genes located in the 129-derived genomic region that flanks the Fcgr2b gene and the C57BL/6 genome result in the development of autoantibodies. Subsequently, FcgRIIB deficiency enhances the Splenic cells from wild-type C57BL/6 and age-matched (∼8 wk) FcgRIIB 129 2/2 male or female mice were prepared, and total cell lysates containing equal amounts of proteins were analyzed by immunoblotting, using Abs specific to the indicated proteins. The fold increases in the p202 protein levels in FcgRIIB 129 2/2 male and female mice (compared with wild-type mice) are indicated. 
